22 results
D
MREO
Mereo Biopharma Group Plc
12 Jun 20
$70M in equity / options / securities to be acquired, sold $70M, 25 investors
12:18pm
Health Care
Biotechnology
Health Insurance
Hospitals & Physicians
Pharmaceuticals
Other Health Care
Manufacturing
Real Estate
Commercial
Construction
S-3
EX-1.2
MREO
Mereo Biopharma Group Plc
15 May 24
Shelf registration
4:49pm
. data privacy and securities laws and U.S. health care fraud and abuse laws, except where noncompliance would not, individually or in the aggregate … by a subsequent submission).
(gg) Compliance with Health Care Laws. The Company has operated and currently is in material compliance with all applicable health
F-3
EX-1.2
MREO
Mereo Biopharma Group Plc
5 Aug 21
Shelf registration (foreign)
4:33pm
privacy and securities laws and U.S. health care fraud and abuse laws, except where noncompliance would not, individually or in the aggregate … ) Compliance with Health Care Laws. The Company has operated and currently is in compliance with all applicable health care laws, rules and regulations
6-K
EX-1.1
MREO
Mereo Biopharma Group Plc
10 Feb 21
Mereo BioPharma Group plc Announces Proposed Public Offering of American Depositary Shares
5:23pm
Food, Drug and Cosmetic Act, U.S. data privacy and securities laws and U.S. health care fraud and abuse laws, except where noncompliance would … , suspension or exclusion from any U.S. federal or state government health care program or human clinical research.
(xxx) Relationships. No relationship
6-K
EX-99.2
MREO
Mereo Biopharma Group Plc
2 Nov 21
Current report (foreign)
4:16pm
business including planned clinical developments and its ongoing clinical studies. COVID-19 continues to impact businesses, economies and health care systems
F-4
EX-10.21
r4v3f
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.22
8ziwlxi
25 Jan 19
Registration of securities (foreign)
12:00am
F-4
EX-10.20
mjn3l mro
25 Jan 19
Registration of securities (foreign)
12:00am
F-3
EX-1.2
bpcfo6k3vq3wp s3m
6 Oct 20
Shelf registration (foreign)
4:25pm
20-F
j8ryi1v8lub s2
29 Apr 19
Annual report (foreign)
4:59pm
F-1/A
44zbii
6 Mar 20
Registration statement (foreign) (amended)
5:32pm
F-1/A
ge7cp3u8vumf nrd
12 Mar 20
Registration statement (foreign) (amended)
5:15pm
10-K
d5849i6 a5e
27 Mar 24
Annual report
5:20pm
424B3
etheiihqcyu6
20 Mar 19
Prospectus supplement
4:58pm
F-4/A
t8uory
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
F-4
lstvz29
25 Jan 19
Registration of securities (foreign)
12:00am
F-3/A
6wy0m sa0kay867uqfp1
27 Sep 21
Shelf registration (foreign) (amended)
4:18pm